Clinical Trials Directory

Trials / Sponsors / BrightGene Bio-Medical Technology Co., Ltd.

BrightGene Bio-Medical Technology Co., Ltd.

Industry · 14 registered clinical trials — 9 currently recruiting.

StatusTrialPhaseStarted
RecruitingBioequivalence Study of BGM0504 Injection
Overweight/Obesity
Phase 12025-12-23
RecruitingA Study of BGM1812 Injection in Healthy and Non-diabetic Overweight or Obese Chinese Participants
Overweight or Obesity
Phase 12025-12-05
RecruitingA Study of BGM0504 Tablets in Healthy and Non-diabetic Overweight or Obese Chinese Subjects
Healthy, Non-diabetic Overweight or Obese
Phase 12025-10-21
RecruitingEvaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM1812 Injection Following Single
Healhty, Overweight or Obesity
Phase 12025-10-09
RecruitingEvaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM0504 Tablets in Non-diabetic Ov
Non-diabetic Overweight or Obese
Phase 12025-08-11
RecruitingA Study of BGM0504 in Participants With Type 2 Diabetes in Indonesia
Type 2 Diabetes (T2DM)
Phase 32025-07-04
CompletedA Study of BGM0504 in Healthy Participants and Participants With Impaired Renal Function
Type 2 Diabetes Mellitus (T2DM), Overweight or Obese
Phase 12025-05-06
RecruitingA Study of BGM0504 in Participants With Obesity
Obesity
Phase 22025-04-03
CompletedA Study of BGM0504 in Overweight or Obese Participants
Overweight or Obese
Phase 12025-03-24
RecruitingA Study of BGM0504 in Poorly Controlled Type 2 Diabetes Patients Only Through Diet and Exercise
Type 2 Diabetes Mellitus (T2DM)
Phase 32024-12-02
RecruitingA Study of BGM0504 in Participants with Type 2 Diabetes
Type 2 Diabetes Mellitus (T2DM)
Phase 32024-11-29
CompletedEvaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM0504 Injection in Non-diabetic
Non-diabetic Overweight or Obese
Phase 12024-10-21
CompletedA Study of BGM0504 Evaluating Weight Loss in Overweight or Obese Chinese Subjects
Overweight or Obesity
Phase 22023-10-13
CompletedA Study of BGM0504 in Chinese Patients With Type 2 Diabetes
Type 2 Diabetes
Phase 22023-08-30